Live Breaking News & Updates on Cogent Research Team

Stay updated with breaking news from Cogent research team. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer

Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Christi Waarich , Andrew Robbins , Cole Pinnow , Olaf College , Master Of Sciences , Cogent Biosciences Inc , Abbott Laboratories , Booth School Of Management , Master Of Business Administration , Cogent Research Team , Compensation Committee Of Cogent Board Directors , Iowa State University , University Of Chicago , Biosciences Appoints Cole Pinnow , Chief Commercial , Gastrointestinal Stromal Tumors , Chief Executive , Managing Director , Pfizer Canada , Global Franchise Lead , Breast Cancer Business , Business Administration , Booth School , Iowa State , Listing Rule ,

Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting - Cogent Biosciences (NASDAQ:COGT)

Bezuclastinib + sunitinib combination therapy reached median progression free survival (mPFS) of 19.4-months and 33% ORR in subset of advanced GIST patients with one prior treatment Encouraging long-term safety and ....

United States , Andrew Robbins , Andrew Wagner , Christi Waarich , Alliance For Research , Cogent Biosciences Inc , Cogent Research Team , Life Raft Group , American Society Of Clinical Oncology , Harvard Medical School , Bezuclastinib Clinical Development , Dana Farber Cancer Institute , Dana Farber Cancer , Gastrointestinal Stromal Tumors , American Society , Clinical Oncology , Annual Meeting , Chief Executive Officer , Senior Physician , Bone Oncology , Associate Professor , Harvard Medical , Poster Session , Jefferies Global Healthcare Conference , Cogent Biosciences , Private Securities Litigation Reform Act ,

Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer - Cogent Biosciences (NASDAQ:COGT)

WALTHAM, Mass. and BOULDER, Colo., May 23, 2024 (GLOBE NEWSWIRE) Cogent Biosciences, Inc. (NASDAQ:COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today ....

United States , Andrew Robbins , Christi Waarich , Cogent Biosciences Inc , Compensation Committee Of Cogent Board Directors , Olaf College , University Of Chicago , Master Of Business Administration , Iowa State University , Abbott Laboratories , Master Of Sciences , Cogent Research Team , Booth School Of Management , Cole Pinnow , Chief Commercial , Gastrointestinal Stromal Tumors , Chief Executive , Managing Director , Pfizer Canada , Global Franchise Lead , Breast Cancer Business , Business Administration , Booth School , Iowa State , Listing Rule , Nasdaq Stock ,

Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor

IND-enabling studies expected to begin mid-2024WALTHAM, Mass. and BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced new preclinical data from the Company’s potent, selective, CNS-penetrant ErbB2 inhibitor program. The data are being presented in a poster session at the American Association for Cancer Research (AACR) 2024 Annual Meeting taki ....

United States , San Diego , Andrew Robbins , Christi Waarich , Cogent Biosciences Inc , Company Erb , Cogent Research Team , American Association For Cancer Research , American Association , Cancer Research , Chief Executive , Novel Mutant Selective , Activity Across Activating Mutations , Drug Design , Poster Section , Board Number , Abstract Number , Cogent Biosciences , Private Securities Litigation Reform Act , Annual Report , Novel Therapies , Isease Populations , Forward Looking Statements , Tyrosine Kinase Inhibitor , Biotechnology Company ,

Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis

Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Christi Waarichsenior , Andrew Robbins , Frank Siebenhaar , Cogent Biosciences Inc , Data Monitoring Committee , Bezuclastinib Clinical Development , Cogent Research Team , Head University Outpatient Clinic , Institute Of Allergology , Total Symptom Score , Allergy Asthma , Immunology Annual Meeting , Chief Executive , Reported Outcomes , Mastocytosis Symptom Severity Daily Diary , Mast Cell Quality Of Life , Clinical Development , Independent Data Monitoring Committee , Gastrointestinal Stromal Tumors , Cogent Biosciences , Looking Statementsthis , Private Securities Litigation Reform Act , Quarterly Report , Waarichsenior Director , Investor Relations ,